Epigenetics

13 results.

October 21, 2024 Van Andel Institute Chief Scientific Officer Dr. Peter A. Jones elected to National Academy of Medicine

GRAND RAPIDS, Mich. (Oct. 21, 2024) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has been elected to the

October 10, 2024 Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…

January 11, 2024 ‘A Grand Plan' for achieving breakthroughs and improving health

Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…

September 28, 2023 Van Andel Institute chief scientist earns $7.9 million Outstanding Investigator Award to support cancer research

GRAND RAPIDS, Mich. (September 28, 2023) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has received a seven-year, nearly…

August 3, 2023 Making an impact in the real-world: Five things to know about the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team

Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…